Wegovy, Ozempic & Rybelsus: Novo Nordisk Cuts Prices by Up to 50% in 2027
In a significant move aimed at increasing access to its popular medications, Novo Nordisk announced plans to substantially lower the list prices of Wegovy, Ozempic, and Rybelsus in the United States. Starting January 1, 2027, all three drugs – used for both weight management and type 2 diabetes – will be priced at $675 per … Read more